Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants.
Blanco P, Hernando-Amado S, Reales-Calderon JA, Corona F, Lira F, Alcalde-Rico M, Bernardini A, Sanchez MB, Martinez JL. · 2016
Read Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants. by Blanco P, Hernando-Amado S, Reales-Calderon JA, Corona F, Lira F, Alcalde-Rico M, Bernardini A, Sanchez MB, Martinez JL. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5029519.txt.
Introduction
Paula Blanco and nine co-authors review bacterial efflux pumps in Microorganisms in 2016. Efflux pumps are protein machines that push substances out of bacterial cells, and they are famous for ejecting antibiotics, which makes infections hard to treat. Yet the pumps sit in the chromosomes of nearly all bacteria and long predate medical antibiotic use, so resistance is unlikely to be their first job.
The review catalogs their wider work: clearing heavy metals, pollutants, and the cell's own toxic waste, passing chemical signals between bacteria, and helping bacteria infect plants and animals. It also covers how cells switch the pumps on in answer to set signals. A final section surveys the hunt for pump blockers that could restore antibiotic power. The overall picture is of ancient, many-purpose tools that medicine happens to collide with.
Catalog record
| CREATOR | Blanco P, Hernando-Amado S, Reales-Calderon JA, Corona F, Lira F, Alcalde-Rico M, Bernardini A, Sanchez MB, Martinez JL. |
|---|---|
| YEAR | 2016 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants By Paula Blanco, Sara Hernando-Amado, Jose Antonio Reales-Calderon, Fernando Corona, Felipe Lira, Manuel Alcalde-Rico, Alejandra Bernardini, Maria Blanca Sanchez, Jose Luis Martinez, Laurent Poirel Published in: Microorganisms DOI: 10.3390/microorganisms4010014 ABSTRACT Bacterial multidrug efflux pumps are antibiotic resistance determinants present in all microorganisms. With few exceptions, they are chromosomally encoded and present a conserved organization both at the genetic and at the protein levels. In addition, most, if not all, strains of a given bacterial species present the same chromosomally-encoded efflux pumps. Altogether this indicates that multidrug efflux pumps are ancient elements encoded in bacterial genomes long before the recent use of antibiotics for human and animal therapy. In this regard, it is worth mentioning that efflux pumps can extrude a wide range of substrates that include, besides antibiotics, heavy metals, organic pollutants, plant-produced compounds, quorum sensing signals or bacterial metabolites, among others. In the current review, we present information on the different functions that multidrug efflux pumps may have for the bacterial behaviour in different habitats as well as on their regulation by specific signals. Since, in addition to their function in non-clinical ecosystems, multidrug efflux pumps contribute to intrinsic, acquired, and phenotypic resistance of bacterial pathogens, the review also presents information on the search for inhibitors of multidrug efflux pumps, which are currently under development, in the aim of increasing the susceptibility of bacterial pathogens to antibiotics. 1. INTRODUCTION Resistance to antibiotics can be explained in biochemical terms as the inability of a given antibiotic to reach its microbial target at an adequate concentration for inhibiting the target's activity. Within this scope, there are two main ways of acquiring resistance: decreasing the affinity of the target for the antibiotic (mutations in genes encoding the antimicrobial targets) or diminishing the active concentration of the antibiotic inside the cell. For the latter, the mechanisms of resistance can be broadly classified in three categories: (i) production of hydrolytic or modifying enzymes; (ii) mutations in antibiotics' transporters impeding their entrance; and (iii) use of energy-dependent efflux pumps to extrude the antibiotics, impairing their accessibility to the target. Efflux pumps were firstly described as a mechanism of resistance to tetracycline in Escherichia coli [1]. However, nowadays it is well known that efflux pumps constitute the most ubiquitous type of resistance element, present in all organisms from bacteria to mammals, among those that have been described [2,3]. In several cases, the acquisition of resistance to multiple antimicrobials is the consequence of the presence in the same genetic mobile element of several genes, each one encoding a different resistance determinant (co-resistance). However, in some occasions the same determinant can confer resistance to different antimicrobials (cross-resistance). The most conspicuous examples of determinants conferring cross-resistance to different antibiotics are multidrug resistance (MDR) efflux pumps. As stated above, these transporters are present in all organisms, including, in addition to bacterial pathogens [4,5], human cells [6] and eukaryotic pathogens such as Candida albicans [7] or Plasmodium falciparium [8]. It is to be noticed that the efflux systems can actively extrude a variety of compounds; not just conventional antimicrobials, but also non-antibiotic substrates such as dyes, detergents, heavy metals, and organic solvents, among others [9,10,11]. In the prokaryotic kingdom there are five major families of efflux transporters (Figure 1): the adenosine triphosphate (ATP)-binding cassette (ABC) superfamily [12], the resistance-nodulation-division (RND) family [13], the small multidrug resistance (SMR) family [14], the major facilitator superfamily (MFS) [15], and the multidrug and toxic compound extrusion (MATE) family [16]. These families have been defined on the basis of their sequence similarity, substrate specificity, number of components (single or multiple), number of transmembrane-spanning regions, and energy source. The ABC family utilizes ATP hydrolysis to drive the export of substrates, whereas the other families utilize the proton motive force as the energy source. The MFS, ABC, SMR, and MATE families are widely distributed in Gram-positive and Gram-negative bacteria, while the RND superfamily is specific to Gram-negative microorganisms. The members of the RND family are always forming part of a tripartite complex spanning across the two membranes of Gram-negative bacteria [17]. In Gram-positive bacteria, the MFS family is the most relevant efflux pump group, the best studied members of this family being NorA from Staphylococcus aureus and PmrA from Streptococcus pneumoniae [18,19,20]. It is important to remark that efflux pumps are ancient, highly-conserved determinants, which have been selected long before the recent use of antibiotics for the therapy of human infections. These characteristics suggest that the role of efflux pumps as relevant antibiotic resistance determinants in bacterial pathogens is a recent event, likely secondary to other functional roles with relevance to bacterial physiology [3,21,22]. Some of these functional roles not directly linked to antibiotic resistance are discussed below. [Figure: Schematic representation of the main types of bacterial efflux systems. Schematic illustration of the five major families of efflux transporters: the resistance- nodulation-division (RND) family, the small multidrug resistance (SMR) family, the major facilitator superfamily (MFS), the multidrug and toxic compound extrusion (MATE) family and the adenosine triphosphate (ATP)-binding cassette (ABC) superfamily. IM: Inner membrane. OM: Outer membrane. OMP: Outer membrane protein.] 2. MULTIDRUG EFFLUX PUMPS AND ANTIBIOTIC RESISTANCE The possibility that bacteria can acquire resistance by extruding antibiotics was firstly described in 1980, when McMurry and colleagues described the existence of plasmid-encoded proteins capable of extruding tetracycline and conferring resistance to this antibiotic in E. coli [1]. Although the mechanism was novel, its finding still fitted into the paradigm of acquisition of resistance genes: they confer resistance to one structural family of antibiotics and are acquired through horizontal gene transfer (HGT), likely from antibiotic producers [23,24]. Nevertheless, the finding two years later of a chromosomally-encoded efflux pump, not acquired through HGT and conferring resistance to several drugs [25], challenged this paradigm. Indeed, differing to classical resistance elements, multidrug efflux pumps are present in all organisms and are well conserved among the different members of a given species. Expression of MDR efflux pumps is tightly regulated [26]; some of them are expressed at moderate levels, in which case they contribute to intrinsic resistance, whereas for some others the level of expression is very low, at least under laboratory growing conditions. In both cases, a higher level of expression and hence of antimicrobial resistance can be achieved in two ways (Figure 2); transiently, in the presence of inducers of the efflux pumps' expression (see below), or constitutively, due to mutations in the elements that downregulate their expression [27]. Several studies have highlighted the contribution of MDR efflux pumps to the acquisition of multidrug resistance by different pathogens [5,28,29,30]. In this regard, it is important to note that while HGT is an important event in spreading resistance, this mechanism requires the presence of a donor of the resistance gene and is less suitable to occur during single-pathogen infections, including chronic infections. For this type of infections, mutation-driven resistance is likely a more frequent mechanism to acquire resistance to antibiotics. Indeed, during antibiotic treatments of infected and/or colonized patients, bacteria may develop resistance to multiple drugs [31]. This observation can be explained either by the in vivo acquisition of genetic mobile elements carrying multiple antibiotic resistance genes [32], or by the selection